The Impact of Microsoft’s Massive Acquisition of Nuance

In this video take, the Six Five team discusses Microsoft’s acquisition of Nuance. What will this mean for the tech giant?

Check out the clip below:

If you are interested in watching the full episode you can check it out here.

Disclaimer: The Six Five Insiders Webcast is for information and entertainment purposes only. Over the course of this podcast, we may talk about companies that are publicly traded and we may even reference that fact and their equity share price, but please do not take anything that we say as a recommendation about what you should do with your investment dollars. We are not investment advisors and we do not ask that you treat us as such.

Transcript:

Patrick Moorhead: Let’s move forward, Daniel, to the next topic. Microsoft buying Nuance. My gosh, what is Microsoft doing? This is the second massive acquisition here in how long? Is this a new strategy for them?

Daniel Newman: Well, maybe they’ll close Discord next week and they can just go for … What are these? 11-figure deal of the week?

Patrick Moorhead: I know. 11 figures. Gosh, it’s crazy.

Daniel Newman: Pat, this deal kind of … Again, all the energy was around Discord. Everybody thought the next big acquisition was going to be Discord. Then all of a sudden on, I think the weekend, Bloomberg story broke about Nuance. Now, look, Nuance is not a company that hasn’t been on the radar. Apple has been looking at the company, Microsoft, there’s a series of other tech hosts. I went on CNBC. I talked about it with Brian Sullivan. It was funny. He kept asking me about all the value that someone could’ve gotten by buying this company a couple of years ago.

Well, look, crystal balls are crystal balls, but the long and short is, we had a year of healthcare trauma in this country. We are recovering from trauma in the healthcare industry. There is a massive opportunity. Microsoft just doubled its healthcare TAM from 250 billion to 500 billion because AI in healthcare is a huge opportunity. That’s what it comes down to.

Right now the entire experience of going to the doctor and getting your interaction it’s so bureaucratic. It’s so administrative. You have no ability to sit and have a conversation because all the doctor does, right, they come into the room, they ask you a couple of questions. What do they do? They turn to their machine. They get on Epic and they start punching stuff into the system, right?

Ultimately, most of your interaction is with someone at a front desk, a nurse, and then you never talk to your doctor. What if your doctor could come in, interact with you completely naturally, you talk about everything and you used AI to be able to synthesize the conversation, have that data processed to enrich, to actually get clinical information, improve outcomes, and concurrently drive a much better experience? That’s what’s going on here.

You’ve got antiquated systems that do not communicate well with each other. Now all of a sudden the cloud applications that are regulated to integrate with Cerner and Epic, start working together. You apply conversational AI. That’s exactly Nuance is doing. You put all this together and in the end you have a key alignment. You’ve got a market and a TAM opportunity. Did they overpay? Is 16 billion too … Or sorry, 19.7 when you include the debt, is that too much?

Well, if they grow from 250/300 billion in their healthcare business over the next few years, it wasn’t too much. Real quickly, Pat, because I want to leave a little oxygen on this one, but I liken it to a little bit like when IBM bought Red Hat. Everyone said 34 billion too much. The thing was, is it wasn’t just about what Red Hat was doing in Red Hat’s revenue. What it was about was it was about buying a company that can completely legitimize a market that you see as a big opportunity.

Satya was more than clear that he believes this is one of the biggest technologies, AI, in one of the biggest market opportunities, healthcare. Bringing these things together and with Microsoft behind it, you know it’s going to grow faster than it was on its own.

Patrick Moorhead: When you’re worth $2 trillion, overpaying by a billion is almost a rounding error.

Daniel Newman: It’s like you and I leaving like an extra couple of dollars on a tip. I mean, come on.

Patrick Moorhead: No, no. I know. I think the most important thing is probably the impact to OPEX. I know that CNBC was even complaining about this being too low of a price, which sometimes you can’t satisfy that crew.

Daniel Newman: Same I thought it was too much.

Patrick Moorhead: I know, no, I know. No, I think this is a good tuck-in for the company. Microsoft is a trusted provider of healthcare solutions. My brother-in-law’s a surgeon. He’s been using Nuance’s tools for, gosh, years. I mean, I don’t know, a decade or something. He just swears by it and they work for him. Not a lot of value-add there, but Daniel, you added a bunch of it and it was gone. That’s good.

Author Information

Daniel is the CEO of The Futurum Group. Living his life at the intersection of people and technology, Daniel works with the world’s largest technology brands exploring Digital Transformation and how it is influencing the enterprise.

From the leading edge of AI to global technology policy, Daniel makes the connections between business, people and tech that are required for companies to benefit most from their technology investments. Daniel is a top 5 globally ranked industry analyst and his ideas are regularly cited or shared in television appearances by CNBC, Bloomberg, Wall Street Journal and hundreds of other sites around the world.

A 7x Best-Selling Author including his most recent book “Human/Machine.” Daniel is also a Forbes and MarketWatch (Dow Jones) contributor.

An MBA and Former Graduate Adjunct Faculty, Daniel is an Austin Texas transplant after 40 years in Chicago. His speaking takes him around the world each year as he shares his vision of the role technology will play in our future.

Related Insights
CodeRabbit Triage: Fixing the PR Inbox That Cries Wolf
September 20, 2026

CodeRabbit Triage: Fixing the PR Inbox That Cries Wolf

CodeRabbit launched Triage on September 18, 2026, using AI-assisted scoring to automatically prioritize pull requests—addressing a critical pain point for the 46.8% of organizations targeting software engineering as a top...
Cisco and NVIDIA Bring Splunk AI to Enterprises
September 18, 2026

Cisco and NVIDIA Bring Splunk AI to Enterprises

Fernando Montenegro, VP at The Futurum Group, shares insights on Splunk AI, the Cisco–NVIDIA partnership, and enterprise requirements for hybrid deployment....
Salesforce and Google Cloud Expand Access to CRM Workflows
September 18, 2026

Salesforce and Google Cloud Expand Access to CRM Workflows

Keith Kirkpatrick, Research Director at The Futurum Group, examines Salesforce’s Google Cloud expansion and the tests ahead for enterprise workflows and commerce....
Zscaler Launches Agentic SOC, Betting on Telemetry Over Model Horsepower
September 18, 2026

Zscaler Launches Agentic SOC, Betting on Telemetry Over Model Horsepower

Fernando Montenegro, VP at Futurum, analyzes Zscaler's launch of Agentic SOC and why its inline telemetry, decoy mesh, and Red Canary detection matter more than the AI agents themselves....
PyTorch Day Japan Brings Open-Source AI to Tokyo
September 18, 2026

PyTorch Day Japan Brings Open-Source AI to Tokyo

PyTorch Day Japan 2026 convenes ML engineers and AI researchers in Tokyo on December 10 to explore sovereign AI development, open-source inference, and enterprise adoption....
Thales HexaForce: Can Sovereign AI C2 Capture NATO's Next Wave?
September 18, 2026

Thales HexaForce: Can Sovereign AI C2 Capture NATO's Next Wave?

Thales launched HexaForce, an AI-enhanced command and control system validated at NATO CWIX 2026, positioning the company to capture growing allied defense spending on interoperable security solutions....

Book a Demo

Welcome

The vision behind everything in Futurum’s Custom Research practice is this: research should show you what is happening, what comes next, and what to do about it. It should be personal to each audience, easy for people to grasp, and structured so LLMs can reason over it accurately. And it should be fast and turnkey; you want answers now, not another project to carry for quarters.

Whether you are defining business, channel, or go-to-market strategy; evaluating vendors or justifying ROI; or commissioning research to fill an emerging market need, we have your back, with a program that answers your questions with the objectivity and credibility to drive real decisions.

To do it, we bring unmatched data to bear: Futurum research, surveys, and market projections; validated market feeds; ETR’s 15 years of insight from 10,000 technology decision-makers; G2’s buyer and user data; and what our analysts hear every day. Add leading primary collection, from AI-moderated voice interviews to surveys and analyst-led interviews, all turnkey, and every project comes out credible, nuanced, and actionable.

And we don’t just drop the results in your lap. For internal work, we provide analyst-led sessions, interactive dashboards, and a range of formats. For market-facing work, Futurum delivers turnkey activation and amplification that actually gets seen, by people and by LLMs, through our media and share of voice. This is research that moves decisions and markets.

We will meet you wherever you are, from a fast-turn brief to a multi-year program, and shape the work to your goals, timeline, and budget. The right program for your moment.

If any of this is useful, I would love to talk.

Benjamin Brown, VP Custom Research, Futurum Research

Benjamin Brown

VP, Custom Research · The Futurum Group

Newsletter Sign-up Form

Get important insights straight to your inbox, receive first looks at eBooks, exclusive event invitations, custom content, and more. We promise not to spam you or sell your name to anyone. You can always unsubscribe at any time.

All fields are required






Thank you, we received your request, a member of our team will be in contact with you.